StockData
Teva Pharmaceutical Industries Ltd logo

Teva Pharmaceutical Industries Ltd

TEVANYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/30128% above fair value
$42.62+0.05 (+0.12%)

Close on Nov 17, 2026Market cap $49.66BP/E 71.0Yield –

Teva Pharmaceutical Industries TAPI Disposal Group by Quarter

TAPI Disposal Group — Total Liabilities Held for Sale ($M)

Teva Pharmaceutical Industries TAPI Disposal Group: $296M in Q3 2026, down 8.6% from a year earlier.

Latest, Q3 2026
296
Period ended Sep 30, 2026
Change on a year earlier
-8.6%
324 in Q3 2025
History
21 quarters
Since Q4 2017
Sources
20
Documents cited below

Where the Q3 2026 figure comes from

Source: SEC Form 10-Q (0000818686-26-000006) ↗

Reported in SEC Form 10-K / Form 10-Q (XBRL & Footnotes).

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedTAPI Disposal Group — Total Liabilities Held for Sale ($M)Year on yearSource
Q3 2026Sep 30, 2026296-8.6%SEC Form 10-Q (0000818686-26-000006) ↗
Q2 2026Jun 30, 2026313-6.3%SEC Form 10-Q (0001193125-26-323619) ↗
Q1 2026Mar 31, 2026334-6.7%SEC Form 10-Q (0001193125-26-191513) ↗
Q4 2025Dec 31, 2025354-49.3%SEC Form 10-Q (0000818686-26-000006) ↗
Q3 2025Sep 30, 2025324+50.0%SEC Form 10-Q (0001193125-25-266895) ↗
Q2 2025Jun 30, 2025334-6.2%SEC Form 10-Q (0001193125-25-169296) ↗
Q1 2025Mar 31, 2025358+36.6%SEC Form 10-Q (0001193125-25-114889) ↗
Q4 2024Dec 31, 2024698+5,269.2%SEC Form 10-K (0001193125-26-034532) ↗
Q3 2024Sep 30, 2024216+1,863.6%SEC Form 10-Q (0001193125-24-252039) ↗
Q2 2024Jun 30, 2024356+2,866.7%SEC Form 10-Q (0001193125-24-189924) ↗
Q1 2024Mar 31, 2024262–SEC Form 10-Q (0001193125-24-134200) ↗
Q4 2023Dec 31, 202313–SEC Form 10-K (0001193125-25-020826) ↗
Q3 2023Sep 30, 202311–SEC Form 10-Q (0001193125-23-274495) ↗
Q2 2023Jun 30, 202312–SEC Form 10-Q (0001193125-23-201707) ↗
Q4 2022Dec 31, 20220-100.0%SEC Form 10-K (0001193125-24-031005) ↗
Q3 2022Sep 30, 20220–SEC Form 10-Q (0001193125-22-276883) ↗

Cite this data

StockData. (2026). Teva Pharmaceutical Industries TAPI Disposal Group ($M), quarterly Q4 2017–Q3 2026 [Data set]. Compiled from Teva Pharmaceutical Industries SEC filings and investor materials. https://stockdatahq.com/stocks/teva/kpis/sub-tapi-hfs-liab

See every metric in the Teva Pharmaceutical Industries KPI table. Data updated Nov 10, 2026.

See a number that looks wrong?